Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
Objectives: Data on lopinavir/ritonavir tablets administered once daily in children are limited. We compared the pharmacokinetics (PK) of lopinavir/ritonavir twice daily versus once daily in virologically suppressed, HIV-infected children, and assessed the virological outcome, at 48 weeks, in childr...
Saved in:
Main Authors: | Chokephaibulkit K., Nuntarukchaikul M., Phongsamart W., Wittawatmongkol O., Lapphra K., Vanprapar N., Cressey T.R. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84869462249&partnerID=40&md5=afdc589e473e64d7a54b76da5bcdce53 http://cmuir.cmu.ac.th/handle/6653943832/903 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
by: Kulkanya Chokephaibulkit, et al.
Published: (2018) -
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
by: Kulkanya Chokephaibulkit, et al.
Published: (2018) -
Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected children
by: Chokephaibulkit K., et al.
Published: (2014) -
Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected children
by: K. Chokephaibulkit, et al.
Published: (2018) -
Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected children
by: K. Chokephaibulkit, et al.
Published: (2018)